Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

What the Puerto Rican hurricanes make visible: Chronicle of a public health disaster foretold.

Benach J, Díaz MR, Muñoz NJ, Martínez-Herrera E, Pericàs JM.

Soc Sci Med. 2019 Jun 12:112367. doi: 10.1016/j.socscimed.2019.112367. [Epub ahead of print] Review.

PMID:
31213368
2.

Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.

Pericàs JM, Nathavitharana R, Garcia-de-la-Mària C, Falces C, Ambrosioni J, Almela M, García-González J, Quintana E, Marco F, Moreno A, Bayer AS, Miró JM, Karchmer AW; Hospital Clínic Endocarditis Study Group.

Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00516-19. doi: 10.1128/AAC.00516-19. [Epub ahead of print]

PMID:
31182540
3.

Corrigendum to "association between the timing of surgery for complicated, left-sided infective endocarditis and survival", American HeartJournal 2019, volume 210, April 2019, pages 108-116.

Wang A, Chu VH, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Barsic B, Giannitsioti E, Hurley JP, Hannan MM, Park LP; ICE-PLUS Investigators.

Am Heart J. 2019 Jun;212:165. doi: 10.1016/j.ahj.2019.03.006. Epub 2019 Apr 16. No abstract available.

PMID:
31003633
4.

The association between vegetation size and surgical treatment on 6-month mortality in left-sided infective endocarditis.

Fosbøl EL, Park LP, Chu VH, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Rizk H, Barsic B, Giannitsioti E, Hurley JP, Hannan MM, Wang A; ICE-PLUS Investigators.

Eur Heart J. 2019 Apr 12. pii: ehz204. doi: 10.1093/eurheartj/ehz204. [Epub ahead of print]

PMID:
30977784
5.

Role of age and comorbidities in mortality of patients with infective endocarditis.

Armiñanzas C, Fariñas-Alvarez C, Zarauza J, Muñoz P, González Ramallo V, Martínez Sellés M, Miró Meda JM, Pericás JM, Goenaga MÁ, Ojeda Burgos G, Rodríguez Álvarez R, Castelo Corral L, Gálvez-Acebal J, Martínez Marcos FJ, Fariñas MC; Spanish Collaboration on Endocarditis — Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en Espana Study Group, Fernández Sánchez F, Noureddine M, Rosas G, de la Torre Lima J, Aramendi J, Bereciartua E, Blanco MJ, Blanco R, Boado MV, Campaña Lázaro M, Crespo A, Goikoetxea J, Iruretagoyena JR, Irurzun Zuazabal J, López-Soria L, Montejo M, Nieto J, Rodrigo D, Rodríguez D, Rodríguez R, Vitoria Y, Voces R, García López MV, Georgieva RI, Ojeda G, Rodríguez Bailón I, Ruiz Morales J, Cuende AM, Echeverría T, Fuerte A, Gaminde E, Goenaga MÁ, Idígoras P, Iribarren JA, Izaguirre Yarza A, Kortajarena Urkola X, Reviejo C, Carrasco R, Climent V, Llamas P, Merino E, Plazas J, Reus S, Álvarez N, Bravo-Ferrer JM, Castelo L, Cuenca J, Llinares P, Miguez Rey E, Rodríguez Mayo M, Sánchez E, Sousa Regueiro D, Martínez FJ, Alonso MDM, Castro B, García Rosado D, Durán MDC, Miguel Gómez MA, Lacalzada J, Nassar I, Plata Ciezar A, Reguera Iglesias JM, Asensi Álvarez V, Costas C, de la Hera J, Fernández Suárez J, Iglesias Fraile L, León Arguero V, López Menéndez J, Mencia Bajo P, Morales C, Moreno Torrico A, Palomo C, Paya Martínez B, Rodríguez Esteban Á, Rodríguez García R, Telenti Asensio M, Almela M, Ambrosioni J, Azqueta M, Brunet M, Bodro M, Cartañá R, Falces C, Fita G, Fuster D, García de la Mària C, Hernández-Meneses M, Llopis Pérez J, Marco F, Miró JM, Moreno A, Nicolás D, Ninot S, Quintana E, Paré C, Pereda D, Pericás JM, Pomar JL, Ramírez J, Rovira I, Sandoval E, Sitges M, Soy D, Téllez A, Tolosana JM, Vidal B, Vila J, Adán I, Bermejo J, Bouza E, Celemín D, Cuerpo Caballero G, Delgado Montero A, Fernández Cruz A, García Mansilla A, García Leoni ME, González Ramallo V, Kestler Hernández M, Hualde AM, Marín M, Martínez-Sellés M, Menárguez MC, Muñoz P, Rincón C, Rodríguez-Abella H, Rodríguez-Créixems M, Pinilla B, Pinto Á, Valerio M, Vázquez P, Verde Moreno E, Antorrena I, Loeches B, Martín Quirós A, Moreno M, Ramírez U, Rial Bastón V, Romero M, Saldaña A, Agüero Balbín J, Amado C, Armiñanzas Castillo C, Arnaiz García A, Cobo Belaustegui M, Fariñas MC, Fariñas-Álvarez C, Gómez Izquierdo R, García I, González-Rico C, Gutiérrez-Cuadra M, Gutiérrez Díez J, Pajarón M, Parra JA, Sarralde A, Teira R, Zarauza J, Domínguez F, García Pavía P, González J, Orden B, Ramos A, Centella T, Hermida JM, Moya JL, Martín-Dávila P, Navas E, Oliva E, Del Río A, Ruiz S, Hidalgo Tenorio C, Almendro Delia M, Araji O, Barquero JM, Calvo Jambrina R, de Cueto M, Gálvez Acebal J, Méndez I, Morales I, López-Cortés LE, de Alarcón A, García E, Haro JL, Lepe JA, López F, Luque R, Alonso LJ, Azcárate P, Azcona Gutiérrez JM, Blanco JR, García-Álvarez L, Oteo JA, Sanz M, de Benito N, Gurguí M, Pacho C, Pericas R, Pons G, Álvarez M, Fernández AL, Martínez A, Prieto A, Regueiro B, Tijeira E, Vega M, Canut Blasco A, Cordo Mollar J, Gainzarain Arana JC, García Uriarte O, Martín López A, Ortiz de Zárate Z, Urturi Matos JA, García Domínguez G, Sánchez-Porto A, Arribas Leal JM, García Vázquez E, Hernández Torres A, Blázquez A, de la Morena Valenzuela G, Alonso Á, Aramburu J, Calvo FE, Moreno Rodríguez A, Tarabini-Castellani P, Heredero Gálvez E, Maicas Bellido C, Largo Pau J, Sepúlveda MA, Toledano Sierra P, Iqbal-Mirza SZ, Cascales Alcolea E, Egea Serrano P, Hernández Roca JJ, Keituqwa Yañez I, Peláez Ballesta A, Soriano V, Moreno Escobar E, Peña Monje A, Sánchez Cabrera V, Vinuesa García D, Arrizabalaga Asenjo M, Cifuentes Luna C, Núñez Morcillo J, Pérez Seco MC, Villoslada Gelabert A, Aured Guallar C, Fernández Abad N, García Mangas P, Matamala Adell M, Palacián Ruiz MP, Porres JC, Alcaraz Vidal B, Cobos Trigueros N, Del Amor Espín MJ, Giner Caro JA, Jiménez Sánchez R, Jimeno Almazán A, Ortín Freire A, Viqueira González M, Pericás Ramis P, Ribas Blanco MÁ, Ruiz de Gopegui Bordes E, Vidal Bonet L, Bellón Munera MC, Escribano Garaizabal E, Tercero Martínez A, Segura Luque JC.

Eur J Intern Med. 2019 Jun;64:63-71. doi: 10.1016/j.ejim.2019.03.006. Epub 2019 Mar 21.

PMID:
30904433
6.

Hepatitis C services at harm reduction centres in the European Union: a 28-country survey.

Pericàs JM, Bromberg DJ, Ocampo D, Schatz E, Wawer I, Wysocki P, Safreed-Harmon K, Lazarus JV.

Harm Reduct J. 2019 Mar 21;16(1):20. doi: 10.1186/s12954-019-0290-x.

7.

Association between the timing of surgery for complicated, left-sided infective endocarditis and survival.

Wang A, Chu VH, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Barsic B, Giannitsioti E, Hurley JP, Hannan MM, Park LP; ICE-PLUS Investigators.

Am Heart J. 2019 Apr;210:108-116. doi: 10.1016/j.ahj.2019.01.004. Epub 2019 Jan 17. Erratum in: Am Heart J. 2019 Jun;212:165.

PMID:
30802708
8.

Outpatient Parenteral Antibiotic Treatment (OPAT) for Infective Endocarditis: a Prospective Cohort Study From the GAMES Cohort.

Pericàs JM, Llopis J, González-Ramallo V, Goenaga MÁ, Muñoz P, García-Leoni ME, Fariñas MC, Pajarón M, Ambrosioni J, Luque R, Goikoetxea J, Oteo JA, Carrizo E, Bodro M, Reguera-Iglesias JM, Navas E, Hidalgo-Tenorio C, Miró JM; GAMES investigators.

Clin Infect Dis. 2019 Jan 14. doi: 10.1093/cid/ciz030. [Epub ahead of print]

PMID:
30649282
9.

Leaving behind pegylated interferon-based regimens to eliminate hepatitis C as a public health threat by 2030 as set out by WHO.

Lazarus JV, Pericàs JM, Elsharkawy AM.

Liver Int. 2018 Nov;38(11):1902-1905. doi: 10.1111/liv.13944. No abstract available.

PMID:
30358061
10.

Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial.

Holland TL, Raad I, Boucher HW, Anderson DJ, Cosgrove SE, Aycock PS, Baddley JW, Chaftari AM, Chow SC, Chu VH, Carugati M, Cook P, Corey GR, Crowley AL, Daly J, Gu J, Hachem R, Horton J, Jenkins TC, Levine D, Miro JM, Pericas JM, Riska P, Rubin Z, Rupp ME, Schrank J Jr, Sims M, Wray D, Zervos M, Fowler VG Jr; Staphylococcal Bacteremia Investigators.

JAMA. 2018 Sep 25;320(12):1249-1258. doi: 10.1001/jama.2018.13155.

11.

Systemic Factors and Barriers That Hamper Adequate Data Collection on the HIV Epidemic and Its Associated Inequalities in Countries With Long-Term Armed Conflicts: Lessons From Colombia.

Alzate Angel JC, Pericàs JM, Taylor HA, Benach J.

Am J Public Health. 2018 Oct;108(10):1341-1344. doi: 10.2105/AJPH.2018.304505. Epub 2018 Aug 23.

PMID:
30138065
12.

Risk factors of pericardial effusion in native valve infective endocarditis and its influence on outcome: A multicenter prospective cohort study.

Regueiro A, Falces C, Pericás JM, Muñoz P, Martínez-Sellés M, Valerio M, Sousa Regueiro D, Castelo L, de Alarcón A, Cobo Belaustegui M, Goenaga MA, Hidalgo-Tenorio C, Martínez-Marcos FJ, Gainzarain Arana JC, Miro JM; y los investigadores del Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES).

Int J Cardiol. 2018 Dec 15;273:193-198. doi: 10.1016/j.ijcard.2018.08.010. Epub 2018 Aug 7.

PMID:
30122503
13.

Viral hepatitis: "E" is for equitable elimination.

Lazarus JV, Pericàs JM, Colombo M, Ninburg M, Wiktor S, Thursz M.

J Hepatol. 2018 Oct;69(4):762-764. doi: 10.1016/j.jhep.2018.06.018. Epub 2018 Jul 23. No abstract available.

PMID:
30049544
14.

Correction: Outcome of Enterococcus faecalis infective endocarditis according to the length of antibiotic therapy: Preliminary data from a cohort of 78 patients.

Pericàs JM, Cervera C, Moreno A, Garcia-de-la-Mària C, Almela M, Falces C, Quintana E, Vidal B, Llopis J, Fuster D, Mestres CA, Marco F, Miró JM; Hospital Clinic Endocarditis Study Group.

PLoS One. 2018 Apr 19;13(4):e0196317. doi: 10.1371/journal.pone.0196317. eCollection 2018.

15.

The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis.

García-de-la-Mària C, Gasch O, García-Gonzalez J, Soy D, Shaw E, Ambrosioni J, Almela M, Pericàs JM, Tellez A, Falces C, Hernandez-Meneses M, Sandoval E, Quintana E, Vidal B, Tolosana JM, Fuster D, Llopis J, Pujol M, Moreno A, Marco F, Miró JM.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e02633-17. doi: 10.1128/AAC.02633-17. Print 2018 Jun.

16.

Outcome of Enterococcus faecalis infective endocarditis according to the length of antibiotic therapy: Preliminary data from a cohort of 78 patients.

Pericàs JM, Cervera C, Moreno A, Garcia-de-la-Mària C, Almela M, Falces C, Quintana E, Vidal B, Llopis J, Fuster D, Mestres CA, Marco F, Miró JM; Hospital Clinic Endocarditis Study Group.

PLoS One. 2018 Feb 20;13(2):e0192387. doi: 10.1371/journal.pone.0192387. eCollection 2018. Erratum in: PLoS One. 2018 Apr 19;13(4):e0196317.

17.

Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial.

Pericàs JM, Moreno A, Almela M, García-de-la-Mària C, Marco F, Muñoz P, Peña C, de Alarcón A, Del Río A, Eworo A, Cruceta A, Paré JC, Mestres CA, Miró JM; FOSIMI Investigators.

Clin Microbiol Infect. 2018 Jun;24(6):673-676. doi: 10.1016/j.cmi.2018.01.010. Epub 2018 Feb 3. No abstract available.

18.

Inequalities in global health inequalities research: A 50-year bibliometric analysis (1966-2015).

Cash-Gibson L, Rojas-Gualdrón DF, Pericàs JM, Benach J.

PLoS One. 2018 Jan 31;13(1):e0191901. doi: 10.1371/journal.pone.0191901. eCollection 2018.

19.

Epidemiology, Clinical Features, and Outcome of Infective Endocarditis due to Abiotrophia Species and Granulicatella Species: Report of 76 Cases, 2000-2015.

Téllez A, Ambrosioni J, Llopis J, Pericàs JM, Falces C, Almela M, Garcia de la Mària C, Hernandez-Meneses M, Vidal B, Sandoval E, Quintana E, Fuster D, Tolosana JM, Marco F, Moreno A, Miro JM; Hospital Clínic Infective Endocarditis Investigators.

Clin Infect Dis. 2018 Jan 6;66(1):104-111. doi: 10.1093/cid/cix752.

PMID:
29020360
20.

Mortality decrease according to socioeconomic groups.

Pericàs JM, Clotas C, Padrosa E, Fernandez A.

Lancet. 2017 May 6;389(10081):1794. doi: 10.1016/S0140-6736(17)31160-1. Epub 2017 May 4. No abstract available.

PMID:
28495162
21.

AUC/MIC Pharmacodynamic Target Is Not a Good Predictor of Vancomycin Efficacy in Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis.

Castañeda X, García-de-la-Mària C, Gasch O, Pericas JM, Armero Y, Soy D, García-González J, Falces C, Ninot S, Almela M, Ambrosioni J, Quintana E, Vidal B, Fuster D, Llopis J, Soto S, Moreno A, Marco F, Miró JM; Hospital Clinic Endocarditis Study Group.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02486-16. doi: 10.1128/AAC.02486-16. Print 2017 Jun.

22.

Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.

Garcia-de-la-Maria C, Xiong YQ, Pericas JM, Armero Y, Moreno A, Mishra NN, Rybak MJ, Tran TT, Arias CA, Sullam PM, Bayer AS, Miro JM.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02418-16. doi: 10.1128/AAC.02418-16. Print 2017 May.

23.

Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.

Pericàs JM, García-de-la-Mària C, Brunet M, Armero Y, García-González J, Casals G, Almela M, Quintana E, Falces C, Ninot S, Fuster D, Llopis J, Marco F, Moreno A, Miró JM; Hospital Clinic Endocarditis Study Group.

J Antimicrob Chemother. 2017 Jun 1;72(6):1714-1722. doi: 10.1093/jac/dkx016.

PMID:
28204495
24.

Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis.

Pericàs JM, Messina JA, Garcia-de-la-Mària C, Park L, Sharma-Kuinkel BK, Marco F, Wray D, Kanafani ZA, Carugati M, Durante-Mangoni E, Tattevin P, Chu VH, Moreno A, Fowler VG Jr, Miró JM; International Collaboration on Endocarditis Microbiology Investigators.

Clin Microbiol Infect. 2017 Aug;23(8):544-549. doi: 10.1016/j.cmi.2017.01.017. Epub 2017 Feb 1.

25.

Relationship Between Enterococcus faecalis Infective Endocarditis and Colorectal Neoplasm: Preliminary Results From a Cohort of 154 Patients.

Pericàs JM, Corredoira J, Moreno A, García-País MJ, Falces C, Rabuñal R, Mestres CA, Alonso MP, Marco F, Quintana E, Almela M, Paré JC, Llopis J, Castells A, Miró JM; Hospital Clínic and Hospital Lucus Augusti Infective Endocarditis Investigators.

Rev Esp Cardiol (Engl Ed). 2017 Jun;70(6):451-458. doi: 10.1016/j.rec.2016.10.013. Epub 2017 Mar 9. English, Spanish.

PMID:
27916708
26.

When will biomedical research enter the 21st century? A 'young' perspective.

Pericàs JM, Nicolás D.

Eur J Clin Invest. 2017 Mar;47(3):270-272. doi: 10.1111/eci.12707. Epub 2017 Feb 10. No abstract available.

PMID:
27885638
27.

Diagnostic Accuracy of 18F-FDG PET/CT in Infective Endocarditis and Implantable Cardiac Electronic Device Infection: A Cross-Sectional Study.

Granados U, Fuster D, Pericas JM, Llopis JL, Ninot S, Quintana E, Almela M, Paré C, Tolosana JM, Falces C, Moreno A, Pons F, Lomeña F, Miro JM; Hospital Clinic Endocarditis Study Group.

J Nucl Med. 2016 Nov;57(11):1726-1732. Epub 2016 Jun 3. Review.

28.

Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis.

Carugati M, Petti CA, Arnold C, Miro JM, Pericàs JM, Garcia de la Maria C, Kanafani Z, Durante-Mangoni E, Baddley J, Wray D, Klein JL, Delahaye F, Fernandez-Hidalgo N, Hannan MM, Murdoch D, Bayer A, Chu VH.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6341-9. doi: 10.1128/AAC.01531-16. Print 2016 Oct.

29.

Colorectal Adenomas.

Pericàs JM, Corredoira J, Miró JM; Hospital Clínic–Lucus Augusti Working Group for Endocarditis.

N Engl J Med. 2016 Jul 28;375(4):387-8. doi: 10.1056/NEJMc1604867. No abstract available.

PMID:
27464214
30.

Endocarditis in patients with ascending aortic prosthetic graft: a case series from a national multicentre registry.

Ramos A, García-Montero C, Moreno A, Muñoz P, Ruiz-Morales J, Sánchez-Espín G, Porras C, Sousa D, Castelo L, Del Carmen Fariñas M, Gutiérrez F, Reguera JM, Plata A, Bouza E, Antorrena I, de Alarcón A, Pericás JM, Gurguí M, Rodríguez-Abella H, Ángel Goenaga M, Antonio Oteo J, García-Pavía P.

Eur J Cardiothorac Surg. 2016 Dec;50(6):1149-1157. doi: 10.1093/ejcts/ezw190. Epub 2016 Jun 9.

PMID:
27283156
31.

Letter by Pericas et al Regarding Article, "Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry".

Pericas JM, Falces C, Miró JM; Hospital Clinic of Barcelona Endocarditis Study Group*.

Circulation. 2015 Dec 8;132(23):e370-1. doi: 10.1161/CIRCULATIONAHA.115.016804. No abstract available.

PMID:
26644253
32.

Neglecting enterococci may lead to a misinterpretation of the consequences of last changes in endocarditis prophylaxis American Heart Association guidelines.

Pericas JM, Falces C, Moreno A, Marco F, Mestres CA, Miro JM; Hospital Clínic Endocarditis Study Group.

J Am Coll Cardiol. 2015 Nov 10;66(19):2156. doi: 10.1016/j.jacc.2015.07.083. No abstract available.

33.

Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.

del Río A, García-de-la-Mària C, Entenza JM, Gasch O, Armero Y, Soy D, Mestres CA, Pericás JM, Falces C, Ninot S, Almela M, Cervera C, Gatell JM, Moreno A, Moreillon P, Marco F, Miró JM; Hospital Clinic Experimental Endocarditis Study Group.

Antimicrob Agents Chemother. 2015 Nov 2;60(1):478-86. doi: 10.1128/AAC.02139-15. Print 2016 Jan.

34.

Response to Letter Regarding Article, "Association Between Surgical Indications, Operative Risk, and Clinical Outcome in Infective Endocarditis: A Prospective Study From the International Collaboration on Endocarditis".

Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Mudrick DW, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Rizk H, Krajinovic V, Giannitsioti E, Hurley JP, Hannan MM, Wang A; ICE Investigators.

Circulation. 2015 Oct 6;132(14):e184-5. doi: 10.1161/CIRCULATIONAHA.115.016782. No abstract available.

PMID:
26438777
35.

Enterococcal endocarditis revisited.

Pericás JM, Zboromyrska Y, Cervera C, Castañeda X, Almela M, Garcia-de-la-Maria C, Mestres C, Falces C, Quintana E, Ninot S, Llopis J, Marco F, Moreno A, Miró JM.

Future Microbiol. 2015;10(7):1215-40. doi: 10.2217/fmb.15.46. Epub 2015 Jun 29. Review.

PMID:
26118390
36.

Clinical MRSA isolates from skin and soft tissue infections show increased in vitro production of phenol soluble modulins.

Berlon NR, Qi R, Sharma-Kuinkel BK, Joo HS, Park LP, George D, Thaden JT, Messina JA, Maskarinec SA, Mueller-Premru M, Athan E, Tattevin P, Pericas JM, Woods CW, Otto M, Fowler VG Jr.

J Infect. 2015 Oct;71(4):447-57. doi: 10.1016/j.jinf.2015.06.005. Epub 2015 Jun 14.

37.

Epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration.

García de la Mària C, Cervera C, Pericàs JM, Castañeda X, Armero Y, Soy D, Almela M, Ninot S, Falces C, Mestres CA, Gatell JM, Moreno A, Marco F, Miró JM; Hospital Clinic Endocarditis Study Group.

PLoS One. 2015 May 11;10(5):e0125818. doi: 10.1371/journal.pone.0125818. eCollection 2015.

38.

Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).

Gudiol F, Aguado JM, Almirante B, Bouza E, Cercenado E, Domínguez MÁ, Gasch O, Lora-Tamayo J, Miró JM, Palomar M, Pascual A, Pericas JM, Pujol M, Rodríguez-Baño J, Shaw E, Soriano A, Vallés J.

Enferm Infecc Microbiol Clin. 2015 Nov;33(9):625.e1-625.e23. doi: 10.1016/j.eimc.2015.03.015. Epub 2015 May 1.

PMID:
25937457
39.

Executive summary of the diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).

Gudiol F, Aguado JM, Almirante B, Bouza E, Cercenado E, Domínguez MÁ, Gasch O, Lora-Tamayo J, Miró JM, Palomar M, Pascual A, Pericas JM, Pujol M, Rodríguez-Baño J, Shaw E, Soriano A, Vallés J.

Enferm Infecc Microbiol Clin. 2015 Nov;33(9):626-32. doi: 10.1016/j.eimc.2015.03.014. Epub 2015 Apr 30.

PMID:
25937456
40.

A case of Mycoplasma hominis disseminated infection in a human immunodeficiency virus-1-infected pregnant woman with hypogammaglobulinemia.

Fernández S, Nicolás D, Pericás JM, Castro Rebollo P, Vila J, Miró JM, Blanco JL, Nicolás JM.

J Microbiol Immunol Infect. 2017 Feb;50(1):118-119. doi: 10.1016/j.jmii.2014.11.006. Epub 2014 Nov 25. No abstract available.

41.

Infective endocarditis in patients with an implanted transcatheter aortic valve: Clinical characteristics and outcome of a new entity.

Pericas JM, Llopis J, Cervera C, Sacanella E, Falces C, Andrea R, Garcia de la Maria C, Ninot S, Vidal B, Almela M, Paré JC, Sabaté M, Moreno A, Marco F, Mestres CA, Miro JM; Hospital Clinic Endocarditis Study Group.

J Infect. 2015 Jun;70(6):565-76. doi: 10.1016/j.jinf.2014.12.013. Epub 2015 Jan 3. Review.

PMID:
25561168
42.

Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis.

Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Mudrick DW, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Rizk H, Krajinovic V, Giannitsioti E, Hurley JP, Hannan MM, Wang A; International Collaboration on Endocarditis (ICE) Investigators*.

Circulation. 2015 Jan 13;131(2):131-40. doi: 10.1161/CIRCULATIONAHA.114.012461. Epub 2014 Dec 5.

PMID:
25480814
43.

Reply to Kaasch et al.

Cervera C, Garcia de la Maria C, Pericas JM, Moreno A, Miro JM.

Clin Infect Dis. 2015 Feb 15;60(4):669-70. doi: 10.1093/cid/ciu875. Epub 2014 Nov 3. No abstract available.

PMID:
25371491
44.

Health Care-Associated Infective Endocarditis: a Growing Entity that Can Be Prevented.

Benito N, Pericas JM, Gurguí M, Mestres CA, Marco F, Moreno A, Horcajada JP, Miró JM.

Curr Infect Dis Rep. 2014 Nov;16(11):439. doi: 10.1007/s11908-014-0439-4.

PMID:
25230606
45.

Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.

Pericas JM, Cervera C, del Rio A, Moreno A, Garcia de la Maria C, Almela M, Falces C, Ninot S, Castañeda X, Armero Y, Soy D, Gatell JM, Marco F, Mestres CA, Miro JM; Hospital Clinic Endocarditis Study Group.

Clin Microbiol Infect. 2014 Dec;20(12):O1075-83. doi: 10.1111/1469-0691.12756. Epub 2014 Aug 11.

46.

[Rhabdomyolysis and severe hepatotoxicity due to a drug-drug interaction between ritonavir and simvastatin. Could we use the most cost-effective statin in all human immunodeficiency virus-infected patients?].

Bastida C, Also MA, Pericas JM, Letang E, Tuset M, Miró JM.

Enferm Infecc Microbiol Clin. 2014 Nov;32(9):579-82. doi: 10.1016/j.eimc.2014.03.014. Epub 2014 Jun 7. Spanish.

PMID:
24913991
47.

[Role of ceftaroline fosamil in the treatment of bacteremia and infectious endocarditis].

Almirante B, Pericás JM, Miró JM.

Enferm Infecc Microbiol Clin. 2014 Mar;32 Suppl 2:44-53. doi: 10.1016/S0213-005X(14)70158-2. Review. Spanish.

PMID:
24702979
48.

Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.

Cervera C, Castañeda X, de la Maria CG, del Rio A, Moreno A, Soy D, Pericas JM, Falces C, Armero Y, Almela M, Ninot S, Pare JC, Mestres CA, Gatell JM, Marco F, Miro JM; Hospital Clinic Endocarditis Study Group.

Clin Infect Dis. 2014 Jun;58(12):1668-75. doi: 10.1093/cid/ciu183. Epub 2014 Mar 18.

PMID:
24647021
49.

Risk factors for pericardial effusion in native valve infective endocarditis and its influence on outcome.

Regueiro A, Falces C, Cervera C, Del Rio A, Paré JC, Mestres CA, Castañeda X, Pericàs JM, Azqueta M, Marco F, Ninot S, Almela M, Moreno A, Miró JM; Hospital Clínic Endocarditis Study Group.

Am J Cardiol. 2013 Nov 15;112(10):1646-51. doi: 10.1016/j.amjcard.2013.07.024. Epub 2013 Sep 19.

PMID:
24055065
50.

Should alternatives to conventional hospitalisation be promoted in an era of financial constraint?

Pericás JM, Aibar J, Soler N, López-Soto A, Sanclemente-Ansó C, Bosch X.

Eur J Clin Invest. 2013 Jun;43(6):602-15. doi: 10.1111/eci.12087. Epub 2013 Apr 17. Review.

PMID:
23590593

Supplemental Content

Loading ...
Support Center